Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025
San Francisco, CA and London, UK
– how will rising demand and technological developments create opportunities?
The market for pre-filled syringes has achieved growth in recent years. In 2009, an estimated 2 billion pre-filled syringe units were sold and the market for that technology was estimated to be worth up to $2.5 billion. There is a trend towards pre-filled drug injection systems, away from vials/ampules, for both new and existing products. Examples are filled glass and plastic syringes, pens and low-volume auto-injection devices, including refills. That sector has shown growth of 10-15% in recent years, forming one of the fastest-expanding sectors in the pharmaceutical industry. In our new report, we predict that the pre-filled drug delivery market will grow steadily from 2010, as the number of products launched in pre-filled injectable forms increases. Medical professionals, patients and other stakeholders see the benefits of that more-convenient system, raising demand at the expense of older formats.
Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025 shows how a range of therapeutic agents – vaccines, insulins, analogues and many other biologicals – drive growth in that sector. Combined with new pre-filled drug delivery systems and healthcare safety and cost-saving initiatives, the market for pre-filled syringes and similar devices will expand steadily. All the therapeutic segments using pre-filled injectables have been growing in revenue, but which will expand fastest in future? What are the therapeutic and commercial trends to watch? How will the global market for pre-filled syringe-type products perform from 2010 to 2025? Our report answers such questions, providing the information that you need.
The range of pre-filled syringes and related products has broadened into many areas, including:
• Vaccines
• Anti-coagulants
• Anti-infectives
• Anti-inflammatory agents
• Haematological agents
• Multiple sclerosis therapies
• Hormone therapies
• Obstetric agents
• Cancer therapies
• Pain relievers.
The pharmaceutical industry accepts pre-filled drug technology as a proven market and the format of choice for many parentally-administered drugs. Because a product’s delivery system can affect patient compliance – influencing therapeutic outcomes, cost-effectiveness and brand image – easier-to-use devices can confer higher sales and market share. Our new report shows how partnerships between companies will be crucial when developing and harnessing pre-filled injection technologies.
Detailed analysis of the pre-filled drug delivery industry and market
Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025 examines that sector through a comprehensive review of information sources. We use primary and secondary research. This report provides unique sales forecasts, market share analyses, discussions of R&D pipeline developments and analyses of commercial drivers and restraints, including SWOT analysis. There are over 110 tables and figures included, as well as two interviews with experts. The result is a comprehensive market- and industry-centred study, with detailed analyses and informed opinion to benefit your work. This primary research is not available anywhere else - so to benefit from this you must read this report.
Why you should buy Pre-Filled Syringes and Related Systems: World Market Outlook 2010-2025
This report gives you the following benefits in particular:
• You will receive a comprehensive analysis of the prospects for pre-filled syringe devices, including predicted revenues and other data, by therapeutic category and leading brand
• You will find out how the pre-filled devices market will change from 2010 to 2025, with sales forecasts for the global market and leading national markets (US, Japan, UK, Germany, France, Spain, Italy, China and India)
• You will discover how the pre-filled drug device sector is evolving to deliver improved ease of use, safety, product stability and patient compliance
• You will discover why legislation is one of the most important drivers of demand for pre-filled injection technology and products
• You will analyse the drivers, restraints, competition and opportunities influencing the pre-filled injection devices industry and market
• You will investigate R&D developments in that sector, with up-and-coming trends highlighted
• You will examine interviews with experts regarding current and future trends, opportunities and commercial drivers in the sector
• You will find out how the pre-filled syringes industry and market are progressing worldwide – technologically and commercially – and what the future holds.
You can obtain this report today
Nobody with an interest in the parenteral drug sector should overlook our new study. Success in the pre-filled drug devices market from 2010 onwards will be characterised by products with superior delivery of high-value biotechnological drugs. Stability, safety, convenience and cost-effectiveness will increase. Rising disease prevalence – coupled with benefits to pharma stakeholders – are drivers of this market. Do you want to harness those opportunities?
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Contact Person
Bijal Patel
bijal.patel@
Direct Line: +44 (0)20 7549 9946
+44 (0)20 7336 6100
Photo:
http://www.prlog.org/
